Truist Securities assumes coverage of Macerich with buy rating, $26 price target
MAC•Truist Securities assumed coverage of Macerich with a buy rating and a $26 price target.
Related News
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
GRAL•
Priority Technology Holdings Inc: B. Riley cuts to neutral from buy, cuts target price to $8.05 from $11
PRTH•
Euro set for biggest weekly fall in months vs dollar as France fiscal trajectory weighs
FXE•
SPX Technologies: Oppenheimer cuts target price to $270 from $280
SPXC•
AC Immune holds extraordinary general meeting
ACIU•